(Q46049456)

English

Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

K M Carlsen

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

L Riis

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

O R Madsen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

publication date

16 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

28

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

1001-1003

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab-induced hepatitis: absence of cross-toxicity with etanercept.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Infliximab-induced hepatitis in a patient with Crohn's disease]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19370307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-009-1179-Y

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19370307

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46049456&oldid=2089388915"